Literature DB >> 11259814

Increased plasma levels of soluble selectins in patients with unstable angina.

E Atalar1, K Aytemir, I Haznedaroğlu, N Ozer, K Ovünç, S Aksöyek, S Kes, S Kirazli, F Ozmen.   

Abstract

BACKGROUND: Inflammation plays an important role in the pathogenesis of unstable angina. Adhesion molecules, such as selectins, mediate the interactions between leukocytes, platelets and endothelial cells during inflammation and thrombogenesis. HYPOTHESIS: The purpose of this study was to determine whether soluble E-selectin, P-selectin and L-selectin levels are increased in patients with unstable angina (UA).
METHODS: Soluble E-, P- and L-selectin levels were measured by enzyme-linked immunoassay in the peripheral blood of 23 patients with UA, 26 patients with stable angina (SA) and 15 control patients with angiographically normal coronary arteries.
RESULTS: Soluble E-selectin levels were significantly higher in patients with UA (45+/-11 ng/ml) than in controls (30+/-8 ng/ml, P<0.001), or patients with SA (34+/-8 ng/ml, P=0.001). Similarly, plasma levels of P- and L-selectin were significantly higher in patients with UA (427+/-144 and 772+/-160 ng/ml, respectively) than in patients with SA (278+/-79 and 643+/-94 ng/ml, respectively, P<0.005 vs. UA for both), or control patients (189+/-43 and 601+/-126 ng/ml, respectively, P=0.001 vs. UA for both).
CONCLUSIONS: Plasma levels of soluble selectins were increased in patients with UA compared with patients with SA or patients without angiographically visible coronary artery disease. Measurements of these adhesion molecules may be helpful as non-invasive markers of coronary plaque destabilization in UA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259814     DOI: 10.1016/s0167-5273(00)00473-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Plasma and serum L-selectin and clinical and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Cecilia Berardi; Paul A Decker; Phillip S Kirsch; Mariza de Andrade; Michael Y Tsai; James S Pankow; Michele M Sale; Hugues Sicotte; Weihong Tang; Naomi Hanson; Joseph F Polak; Suzette J Bielinski
Journal:  Transl Res       Date:  2014-02-21       Impact factor: 7.012

2.  Interleukin-6 and E-selectin in acute coronary syndromes and stable angina pectoris. A comparative study.

Authors:  N Sarrafzadegan; M Sadeghi; F Ghaffarpasand; A Alisaeidi; H Sanei; H Zakeri; T Rastegar; A Amiri; M Dehghankhalili
Journal:  Herz       Date:  2012-07-07       Impact factor: 1.443

3.  Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes.

Authors:  Selçuk Coskun; Enver Atalar; Ercan Ozturk; Bunyamin Yavuz; Necla Ozer; Hakan Goker; Kenan Ovünç; Serdar Aksöyek; Sirri Kes; Bulent Sivri; Serafettin Kirazli; Ferhan Ozmen
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

4.  Analysis of the effects of surface treatments on nickel release from nitinol wires and their impact on candidate gene expression in endothelial cells.

Authors:  E McLucas; Y Rochev; W M Carroll; T J Smith
Journal:  J Mater Sci Mater Med       Date:  2008-02-05       Impact factor: 3.896

5.  A novel multiplex polymerase chain reaction assay for profile analyses of gene expression in peripheral blood.

Authors:  Xingwang Jia; Haiyue Ju; Li Yang; Yaping Tian
Journal:  BMC Cardiovasc Disord       Date:  2012-07-10       Impact factor: 2.298

Review 6.  A head-to-tail view of L-selectin and its impact on neutrophil behaviour.

Authors:  Aleksandar Ivetic
Journal:  Cell Tissue Res       Date:  2018-01-20       Impact factor: 5.249

7.  E-selectin gene haplotypes are associated with the risk of myocardial infarction.

Authors:  Jarosław Gorący; Mariusz Kaczmarczyk; Andrzej Ciechanowicz; Krzysztof Safranow; Joanna Gorący; Katarzyna Jakubowska; Dariusz Chlubek; Iwona Gorący
Journal:  Arch Med Sci       Date:  2019-04-09       Impact factor: 3.318

8.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.